Glaucoma researcher gets grant
Dean McGee Eye Institute researcher Michael H. Elliott has been named an Alcon Research Institute Young Investigator Grant recipient for 2013, joining an international group of scientists being recognized for excellence in ophthalmic research. Elliott, an assistant professor in the University of Oklahoma College of Medicine's Department of Ophthalmology, will use the award to further his research into the role of a specific molecule, caveolin-1 (CAV1), which is linked to a form of glaucoma called primary open-angle glaucoma. Glaucoma is the second-leading cause of blindness worldwide, and primary open-angle glaucoma is the most common type. Dr. Gregory Skuta, CEO of the Dean McGee Eye Institute and Edward L. Gaylord Professor and chair of the OU College of Medicine's Department of Ophthalmology, said Elliot is the institute's first researcher to receive an Alcon young investigator grant, and “another example of why the institute's researchers are among the nation's most highly regarded vision scientists.” The $50,000 Alcon Research Institute Young Investigator Award is intended to encourage and promote the early career development of clinicians and scientists entering research in vision science and ophthalmology.
Orthocare Innovations awarded
The Edison Awards has recognized Orthocare Innovations with its top award in the Science and Medicine — Assistive Device category. Oklahoma City-based Orthocare won the top award for its Magellan microprocessor foot ankle system prosthetic device. Edison Awards recognizes ideas at the forefront of new products, services, marketing, design and innovation. Magellan brings a novel approach to lower limb prosthetics by mimicking key features of the human ankle that are essential to normal gait. Magellan offers active ankle function using microprocessor computer control, combined with micro-hydraulic technology, providing people who have lost limbs with enhanced efficiency, stability and comfort. A key feature is Magellan's connectivity, linking the device to its user and the user's health care providers. This functionality, afforded by iPhone and iPad apps and Bluetooth technology, enables patients to make adjustments to the Magellan themselves, such as adaptations to account for changes in footwear. This functionality also extends to health care providers, affording access to patient performance and device diagnostics.
Yahoo to produce Web series
NEW YORK — A Web series about a 4-inch-tall crime fighter created by “The Office” star Ed Helms is coming to Yahoo. The website announced the series Monday night in a presentation to advertisers in New York. The show is called “Tiny Commando” and stars Helms, “Chuck” actor Zachary Levi and “Community” actress Gillian Jacobs. Following in Netflix's footsteps, Yahoo will release all episodes at once this fall. Yahoo also unveiled two other new series, one starring John Stamos and the other starring Cheryl Hines. Yahoo also announced it's partnering with the WWE to make the Web portal an online hub for professional wrestling videos. Yahoo will produce a 30-minute preshow to the WWE's “Monday Night Raw” and distribute two weekly wrestling series.
Facebook official stepping down
NEW YORK — Facebook says that venture capitalist Jim Breyer won't seek re-election to its board of directors. Facebook Inc. said Friday that Breyer, partner at Silicon Valley VC firm Accel Partners, will stay on until the company's annual meeting on June 11. Menlo Park, Calif.-based Facebook has eight other board members, including CEO Mark Zuckerberg, Chief Operating Officer Sheryl Sandberg and Marc Andreessen, co-founder of Netscape and the venture capital firm Andreessen Horowitz. In an emailed statement, Breyer said that after over eight years of board service, he's stepping aside in light of other responsibilities, including his recent election to the Harvard University Corp. board. According to documents filed with the Securities and Exchange Commission this week, Breyer also isn't seeking re-election to the board of retailer Walmart Stores Inc.
From Staff and Wire Reports